MSCDA Holds Events Throughout the Year

Please Join Us

Maryland Sickle Cell Annapolis Awareness Day 2024 – Virtual Event 3/5/24, In-Person Event 3/22/24

Ignite Change! Join us for Maryland Sickle Cell Annapolis Advocacy 2024 – Be the Voice for Sickle Cell Patients!Join us as we rally together to ...
Read More →

Fertility Talk Webinar – 2/27/2024

Preserving the Future: Fertility & Fertility Preservation Critical Conversation Join Dr. Kamaria Vought and Dr. Lydia Pecker for a critical conversation on the state of ...
Read More →

Rare Disease Week on Capitol Hill – 2/25 – 28 2024

#RareDC2024Rare Disease Week on Capitol Hill empowers and inspires hundreds of advocates each year. The connections you make during the week will impact rare disease ...
Read More →
GET IN TOUCH

We'd Love to Hear from You

Whether you are looking to learn more about our services, and how we can help, or you’re looking for volunteer opportunities, to make a donation, or have any questions about the Maryland Sickle Cell Disease Association, please reach out!
CONTACT US
KEEP IN TOUCH
Sign up for our email list, or follow us on social media, to stay in-the-know about the Maryland Sickle Cell Disease Association
Scroll to Top

Breaking News

FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

On December 8, 2023, “The U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signaling an innovative advancement in the field of gene therapy."